![Rosemary Harrison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rosemary Harrison
Corporate Officer/Principal bei
TCR2 THERAPEUTICS INC.
Profil
Rosemary Harrison is currently the Chief Business & Strategy Officer at TCR2 Therapeutics, Inc. She previously worked as the Senior VP-Corporate Development & Strategy at Trillium Therapeutics ULC from 2020 to 2021, Head-Portfolio Management & Strategic Planning at Novartis Institutes for Biomedical Research, Inc. from 2015 to 2018, and Head-Rare Diseases at Imbria Pharmaceuticals, Inc. from 2019 to 2020.
She holds a doctorate degree from The University of Queensland.
Aktive Positionen von Rosemary Harrison
| Unternehmen | Position | Beginn |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | 01.01.2022 |
Ehemalige bekannte Positionen von Rosemary Harrison
| Unternehmen | Position | Ende |
|---|---|---|
| TRILLIUM THERAPEUTICS | Investor Relations Kontakt | 01.11.2021 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Corporate Officer/Principal | 01.03.2020 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01.05.2018 |
Ausbildung von Rosemary Harrison
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
The University of Queensland
 The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
